10-Q: ModivCare Files 10-Q Amidst Chapter 11 Restructuring

ModivCare Inc. reports significant losses and details its ongoing Chapter 11 bankruptcy proceedings, which will eliminate existing common stock value.

Summary

• ModivCare Inc. commenced voluntary Chapter 11 bankruptcy cases on August 20, 2025, with a pre-arranged joint plan of reorganization confirmed by the Bankruptcy Court on December 15, 2025.
• The restructuring plan aims to significantly deleverage the company's capital structure by approximately $1.1 billion in total funded debt.
• Existing common stock is expected to have no value and will be eliminated upon the plan's effective date, with new equity distributed to certain creditors.
• The company's common stock was delisted from Nasdaq on August 28, 2025, and now trades on the OTC Markets Group under the symbol MODVQ.
• For the three months ended September 30, 2025, ModivCare reported a net loss of $73.1 million, compared to a net loss of $26.6 million in the prior year period.
• Year-to-date September 30, 2025, the company incurred a net loss of $427.2 million, significantly higher than the $177.8 million loss in the same period of 2024.
• Service revenue decreased by 3.2% for the quarter and 4.6% year-to-date, driven by declines in the NEMT, PCS, and Monitoring segments.
• Goodwill impairment charges totaled $263.4 million year-to-date 2025, primarily affecting the PCS ($211.8 million) and Monitoring ($51.6 million) segments.
• The company secured a $100 million Debtor-in-Possession (DIP) financing facility, with an initial draw of $62.5 million, to fund operations during bankruptcy.
• Management has concluded that substantial doubt exists about the company's ability to continue as a going concern.

Sentiment

Score: 1

Explanation: The company is in Chapter 11 bankruptcy, with existing common stock expected to be eliminated, indicating a complete loss for current shareholders. Financial performance shows significant losses and cash burn, and the going concern warning is explicit. While a restructuring plan is confirmed, the outcome for current equity holders is dire.

Positives

• The pre-arranged joint plan of reorganization was confirmed by the Bankruptcy Court on December 15, 2025, providing a clear path forward for restructuring.
• The restructuring is expected to achieve a significant deleveraging of the company's capital structure by approximately $1.1 billion in total funded debt.
• The company secured $100 million in debtor-in-possession (DIP) financing, with an initial draw of $62.5 million, to maintain liquidity and fund operations during the Chapter 11 process.
• NEMT segment operating income increased to $18.5 million in Q3 2025 from $17.3 million in Q3 2024, despite a slight revenue decrease, indicating some operational efficiency improvements.
• PCS segment operating income improved to $4.0 million in Q3 2025 from $0.032 million in Q3 2024, reflecting better cost management relative to revenue decline.
• Cost optimization and digitization efforts in NEMT contact centers led to a decrease in payroll and related costs and other service expenses by $0.6 million in Q3 2025 and $13.9 million year-to-date 2025.
• General and administrative expenses in the NEMT and PCS segments decreased due to efforts to improve operational efficiency.

Negatives

• Existing common stock is expected to have no value and will be eliminated upon the effective date of the Plan, resulting in a complete loss for current shareholders.
• The company reported a net loss of $73.1 million for Q3 2025, a significant increase from the $26.6 million net loss in Q3 2024.
• Year-to-date net loss for 2025 was $427.2 million, substantially worse than the $177.8 million loss for the same period in 2024.
• Consolidated service revenue, net, decreased by $22.3 million (3.2%) in Q3 2025 and $94.9 million (4.6%) year-to-date 2025.
• Operating income shifted to a loss of $12.1 million in Q3 2025 from an income of $5.3 million in Q3 2024.
• Year-to-date operating loss widened to $285.0 million in 2025 from $97.1 million in 2024.
• Goodwill impairment charges of $263.4 million were recorded year-to-date 2025, indicating a significant reduction in asset value.
• Cash and cash equivalents decreased to $78.2 million at September 30, 2025, from $112.6 million at December 31, 2024.
• Total stockholders' equity (deficit) worsened to $(464.1) million at September 30, 2025, from $(38.5) million at December 31, 2024.
• Cash used in operating activities increased significantly to $154.8 million year-to-date 2025, compared to $36.5 million year-to-date 2024.
• The company's common stock was delisted from Nasdaq and now trades on the less liquid Expert Market operated by the OTC Markets Group.
• Increased transportation and caregiver costs, not offset by reimbursement rate increases, have negatively impacted profitability, particularly in the NEMT and PCS segments.
• Lengthened collection periods for accounts receivable due to complexities in Medicare, Medicaid, and nongovernmental payor arrangements continue to negatively impact cash flow and liquidity.
• The Corporate and Other segment's general and administrative expenses increased significantly due to professional and legal fees related to debt transactions and the reorganization.

Risks

• The company is subject to significant risks and uncertainties associated with the Chapter 11 Cases, including potential adverse effects on business, financial condition, results of operations, and liquidity.
• There is no assurance that the Plan will be consummated as outlined in the RSA, or that any new plan would be as favorable to creditors.
• Termination of the RSA could materially and adversely affect the ability to consummate the Plan.
• The RSA is subject to significant conditions and milestones that may be difficult to satisfy, and failure to meet them could lead to termination.
• Operating under Chapter 11 may restrict the company's ability to pursue business strategies and respond to events or opportunities in a timely manner.
• A long and protracted restructuring could materially adversely affect the business, financial condition, results of operations, and liquidity, potentially leading to liquidation.
• The company's historical financial information may be volatile and not indicative of future financial performance due to asset impairments, restructuring activities, and potential fresh start accounting.
• The Chapter 11 Cases consume a substantial portion of management's time and attention, potentially adversely affecting business operations and increasing employee attrition.
• The composition of the Board of Directors may change upon emergence from bankruptcy, potentially altering future strategy and plans.
• Substantial doubt exists about the company's ability to meet its obligations and continue as a going concern.
• Cash flows may not provide sufficient liquidity during or after the Chapter 11 Cases, and exit financing may not be sufficient to support operations.
• Transfers of equity and issuances of equity in connection with the Chapter 11 Cases may impair the ability to utilize federal income tax net operating loss carryforwards.
• The DIP Facility contains restrictions and limitations that could significantly affect the ability to operate the business and liquidity, with breach of covenants potentially leading to default.
• Reliance on a limited number of payors means changes in funding, financial viability, or relationships with these payors could have a material adverse impact.
• The company faces risks of contract termination, renegotiation, or non-renewal, particularly in the NEMT segment, which could materially adversely affect financial condition.
• Recent legislative changes introduced by the One Big Beautiful Bill Act (OBBBA) could adversely affect the business by imposing new restrictions on supplemental benefits, standardized eligibility criteria, and performance-based reimbursement, potentially reducing service volumes and reimbursement rates.
• Trading in the company's securities is highly speculative, and existing common stock is expected to have no value at the effective time of the Plan.
• Trading on the Over-the-Counter Expert Market may result in a less liquid market and further depress the trading price of common stock.
• The reorganized company does not intend to list new common stock on a national securities exchange or be subject to Exchange Act reporting obligations, reducing information available to stockholders.

Future Outlook

The company's future outlook is entirely dependent on the successful implementation and emergence from its Chapter 11 restructuring plan. While the plan has been confirmed, there is no assurance it will become effective as expected, or that the company will generate sufficient liquidity post-restructuring to meet its obligations. The company expects to continue generating negative cash flows from operations in the near term and faces ongoing financial challenges from increased costs, contract losses, and membership declines. The impact of new legislation like the OBBBA also presents risks of decreased membership and constrained reimbursement rates. The company may need to raise additional funds through debt or equity financing after emergence, with no guarantee of favorable terms.

Management Comments

• Management believes that the Restructuring of the Company through the Chapter 11 Cases will allow the Company to successfully emerge and continue to operate as a viable going concern.
• Management has concluded that substantial doubt exists about the Company's ability to continue as a going concern.
• Management does not expect any ongoing surveys, audits or investigations involving the Company to have a material adverse effect on the business, liquidity, financial condition, or results of operations of the Company.
• Management does not expect the ultimate disposition of any or a combination of any ongoing or anticipated legal matters to have a material adverse effect on the business, financial condition or operating results.

Industry Context

The healthcare services industry, particularly non-emergency medical transportation (NEMT), personal care services (PCS), and in-home monitoring, is influenced by an aging population and increasing prevalence of chronic illnesses, driving demand for supportive care. There's a broader shift towards value-based care and increased demand for in-home services, accelerated by technological advancements. However, the industry faces significant challenges from Medicaid redetermination efforts, which have decreased membership, and new regulatory priorities like the CMS final rule requiring 80% of Medicaid payments for direct care workers, potentially lowering PCS profit margins. The recently enacted One Big Beautiful Bill Act (OBBBA) introduces further reforms to Medicare Advantage and Medicaid, potentially limiting supplemental benefits, standardizing eligibility, and constraining reimbursement rates, which could reduce plan flexibility and negatively impact revenue and profitability. Macroeconomic conditions, including high inflation, interest rates, and labor shortages, are increasing operating costs for NEMT and PCS segments, leading to lower profit margins and impacting the ability to provide services at a reasonable cost. Extended collection periods for receivables also pose liquidity challenges.

Comparison to Industry Standards

• The company's significant operating losses and net losses, coupled with its Chapter 11 bankruptcy filing, indicate performance substantially below industry standards for financially healthy healthcare service providers.
• The delisting from Nasdaq and trading on the OTC Expert Market is a clear indicator of severe financial distress, contrasting sharply with publicly traded peers on major exchanges.
• The substantial goodwill impairment charges of $263.4 million in 2025 reflect a significant decline in the estimated fair value of reporting units (PCS and Monitoring), suggesting underperformance relative to initial acquisition expectations and industry growth.
• The inability to offset increased transportation and caregiver costs with corresponding reimbursement rate increases, leading to lower profit margins, highlights a struggle to adapt to macroeconomic pressures that many industry players also face, but with more severe consequences for ModivCare.
• The 'substantial doubt about the company's ability to continue as a going concern' is a critical deviation from the financial stability expected of established companies in the healthcare sector.

Management Changes

Corporate Governance

Legal Proceedings

• A class action complaint was filed on January 29, 2025, alleging federal securities law violations related to the company's NEMT segment accounts receivable collections, cash flow, and contractual payment/collection terms. A lead plaintiff was appointed on October 27, 2025, and an amended complaint is due on January 9, 2026. The company disputes the allegations.
• A shareholder derivative complaint, filed on May 12, 2025, alleged breach of fiduciary duties by current and former directors and executive officers, including issuing false statements and repurchasing stock at inflated prices. This case was voluntarily dismissed on September 15, 2025.
• A class action lawsuit against a PCS segment subsidiary (All Metro Home Care Services of New York) since 2017 claims improper payment of live-in caregivers. The company believes it is compliant and intends to vigorously defend itself.
• All legal proceedings have been automatically stayed as a result of the Chapter 11 Cases, with the stay to be lifted upon the effectiveness of the Plan.

Related Party Transactions

• On January 9, 2025, the company entered into a Purchase and Exchange Agreement with Coliseum Capital Partners, L.P., and Blackwell Partners LLC Series A (Coliseum Investors), related parties. This agreement involved the Coliseum Investors purchasing $30.0 million in aggregate principal amount of the company's Second Lien Notes and exchanging approximately $20.2 million of their 2029 Notes for an equivalent principal amount of Second Lien Notes. These transactions were approved by stockholders on March 13, 2025, and the Second Lien Notes were issued to them on March 14, 2025.

Stakeholder Impact

• Shareholders: Existing common stock is expected to have no value and will be eliminated upon the effective date of the Plan, resulting in a complete loss of investment.
• First Lien Lenders: Approximately $871 million in principal claims will be converted into $200 million of exit debt and 98% of the reorganized company's pro forma equity (subject to dilution).
• Second Lien Noteholders and General Unsecured Claims Holders: Will receive their pro rata share of 2% of the reorganized company's pro forma equity (subject to dilution) and New Warrants (Series A, B, and C).
• Employees: Face increased levels of attrition, distraction, and uncertainty due to the Chapter 11 Cases. Incentive programs are limited, and all outstanding equity awards (stock options, RSUs, PRSUs) ceased vesting and are expected to be cancelled.
• Customers/Payors: May be reluctant to continue utilizing services or maintaining contracts with a company operating under Chapter 11, potentially leading to further contract losses and revenue declines.
• Vendors: May lose confidence in the company's ability to reorganize successfully, potentially impacting supply chain and operational continuity.
• Creditors (general): Pre-petition obligations are classified as 'liabilities subject to compromise' and may not be repaid at their full amount.

Next Steps

• The Plan's effective date is expected no later than December 31, 2025, following an extension of the original milestone.
• The plaintiff in the Dinesh Kalera class action complaint will file an amended complaint on January 9, 2026.
• The company will continue to operate as a debtor-in-possession under the jurisdiction of the Bankruptcy Court.
• The company's ability to continue as a going concern is contingent upon implementing a comprehensive restructuring and generating sufficient liquidity post-restructuring.
• The company may need to raise funds through public or private debt or equity financing after emergence from Chapter 11 protection.
• The reorganized company does not intend to list the new common stock on a national securities exchange or be subject to Exchange Act reporting obligations.

Key Dates

Recommendation

The company has filed for Chapter 11 bankruptcy, and the restructuring plan explicitly states that existing common stock is expected to have no value and will be eliminated. This means current shareholders will lose their entire investment. While the company is undergoing a restructuring, the outcome for existing equity holders is a complete wipeout. Therefore, any remaining shares should be sold immediately if possible, though liquidity is severely limited on the OTC Expert Market.

Keywords

Chapter 11, Bankruptcy, Restructuring, SEC 10-Q, Financial Performance, Net Loss, Goodwill Impairment, Debtor-in-Possession Financing, NEMT, Personal Care Services, In-Home Monitoring, Healthcare Services, Delisting, OTC Markets, Debt Deleveraging, Going Concern, Medicaid, Medicare Advantage, OBBBA